Oracle Platinum Partner to demonstrate expertise in safety and pharmacovigilance, clinical trial management, and clinical data management and EDC
SAINT LOUIS (Sept. 12, 2014) – Perficient, Inc. (NASDAQ: PRFT), a leading information technology and management consulting firm serving Global 2000 and other large enterprise customers throughout North America and Europe, today announced it will serve as an exhibitor sponsor and showcase life sciences solutions at the Oracle Health Sciences User Group’s (OHSUG) 2014 annual conference, held Sept. 14-17 in St. Louis. The meeting brings together leading pharmaceutical, biotechnology and medical device companies, in addition to clinical research organizations, academic institutions and Oracle, to discuss the use, compliance and implementation of Oracle Health Sciences applications.
At the OHSUG conference, Perficient will share its life sciences experience and solution offerings in more than a dozen presentations and demonstrations centered on the practice’s key application areas: clinical trial management, clinical data management and electronic data capture, and safety and pharmacovigilance.
“The depth and breadth of Perficient’s life sciences thought leadership and solution offerings will be on full display at the OHSUG conference,” said Alex Sefanov, general manager of Perficient’s life sciences practice. “In today’s competitive and highly regulated industry landscape, leading edge technologies are needed to augment systems and further innovation. Our seasoned subject matter experts possess broad industry expertise in supporting multiple aspects of clinical trials, as evidenced by the sheer number and variety of seminars we are hosting at this event. In sharing our knowledge and best practices with the larger life sciences community, we seek to help organizations meet their clinical and pharmacovigilance needs for productivity, reliability and value.”
During the conference, Perficient and St. Jude Medical, a Fortune 500 medical device company, will examine why and how St. Jude Medical manages its Oracle Clinical studies using Accel-Copy, a Perficient-developed system accelerator. Designed to increase the effectiveness of clinical teams and the scalability of clinical systems, the Accel-Copy solution copies, migrates and archives studies and global libraries.
In addition to highlighting work with St. Jude Medical, the Perficient team will present the following sessions:
- Migrating Clinical Data in Various Formats to a Clinical Data Management System
- Automatically Retrieving and Loading Data into Siebel CTMS from Multiple CRO Partners
- Combining Clinical, Safety and Operational Data Using Automatic Code Generation
- Supporting the Management of Patient Data with Life Sciences Data Hub
- Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting System with Oracle Empirica Signal
- Understanding the Advantages of CDA
- Using CDA for Reporting Data in Siebel CTMS
- A Path to Freedom: Upgrading to Siebel CTMS Open UI
- Getting the Most Out of Siebel CTMS with APIs
- Improving Site Monitoring with Mobile CRA
- Implementing Digital Signatures in an FDA-Regulated Environment
- New and Emerging Technologies for Conducting Clinical Trials
- Self-Service Account Management for Oracle Clinical/RDC/TMS
- Accelerating the Loading and Versioning of WHO Drug and MedDRA in TMS
Perficient experts also will be available at booths 11 and 12 to discuss their customers’ technology requirements and the overall strategy of Oracle’s life sciences solutions. In addition, visitors to the booths can learn more about Perficient’s wide array of intellectual property assets – applications, utilities and products that enable life sciences clients to speed time to delivery and reduce total cost of ownership, and operate more efficiently. These configurable industry tools can be customized to solve specific enterprise challenges and can be bundled with Perficient services or implemented individually as a point solution.
To register or learn more about the conference, visit www.ohsug.org/events/annual-meetings/2014-annual-conference. For more information on Perficient’s life sciences expertise, visit www.perficient.com/Industries/Life-Sciences and follow @Perficient_LS on Twitter.
Perficient is a leading information technology and management consulting firm serving Global 2000® and enterprise customers throughout North America. Perficient’s professionals serve clients from a network of offices across North America and three offshore locations, in Eastern Europe, India, and China. Perficient helps clients use Internet-based technologies to improve productivity and competitiveness, strengthen relationships with customers, suppliers and partners, and reduce information technology costs. Perficient, traded on the Nasdaq Global Select Market, is a member of the Russell 2000® index and the S&P SmallCap 600 index. Perficient is an award-winning “Premier Level” IBM business partner, a Microsoft National Service Provider and Gold Certified Partner, an Oracle Platinum Partner, a Platinum Salesforce.com Cloud Alliance Partner, a TeamTIBCO partner, and an EMC Select Services Team Partner. For more information, please visit www.perficient.com.
Safe Harbor Statement
Some of the statements contained in this news release that are not purely historical statements discuss future expectations or state other forward-looking information related to financial results and business outlook for 2014. Those statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The “forward-looking” information is based on management’s current intent, belief, expectations, estimates, and projections regarding our company and our industry. You should be aware that those statements only reflect our predictions. Actual events or results may differ substantially. Important factors that could cause our actual results to be materially different from the forward-looking statements include (but are not limited to) those disclosed under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2013 and in our quarterly report on Form 10-Q for the quarter ended June 30, 2014.